The purpose of this paper is to produce the views of parents and siblings of adults with intellectual or developmental disability (ID/DD) around the use of psychotropic medication to manage challenging behaviour (CB) where there is no co-existing mental illness.
Seven family members of six adults with ID/DD were interviewed using semi-structured interviews, over the telephone or face-to-face. The interviews were transcribed, coded and thematically analysed.
This paper identified that if used appropriately, psychotropic medication to manage CB may be of benefit to some people with ID/DD; but there is a need to ensure the medication is prescribed for the benefits of people with ID/DD rather than those around them. Drawing on the knowledge of family may allow for the use of alternative strategies and the reduction of medication to manage CB. There is the need for improved communication with family members, inclusive decision making, and access to information regarding the philosophy and legislation regarding medication used to manage CB in adults with ID/DD.
This paper presents views of a small cohort of family members of people with ID/DD in Queensland, Australia. Findings can be used to improve approaches taken by service providers in their interactions with people with ID/DD prescribed psychotropic medication to manage CB, and their family members.
The authors acknowledge funding from the QUT School of Public Health and Social Work, Queensland Government OPG and Office of the Public Advocate.
Edwards, N., King, J., Watling, H. and Hair, S. (2017), "Qualitative exploration of psychotropic medication to manage challenging behaviour in adults with intellectual disability: views of family members", Advances in Mental Health and Intellectual Disabilities, Vol. 11 No. 5/6, pp. 207-218. https://doi.org/10.1108/AMHID-06-2017-0027Download as .RIS
Emerald Publishing Limited
Copyright © 2017, Emerald Publishing Limited